Related Experiment Videos
Application of miniosmotic pumps for liposomal drug delivery to the ocular lens
Abstract:
The feasibility of using miniosmotic pumps in conjunction with specifically targeted liposomes to deliver agents directly to the ocular lenses of rabbits in vivo was examined in a pilot study. Concanavalin A was used to provide specific targeting of the vesicles to the lenses of the treated eyes. Seven days after pump installation, the animals were sacrificed and tissue samples from both control and treated eyes were examined for the presence of the administered agent. Four animals were treated with liposomally encapsulated Sorbinil and specific delivery to the lenses of the treated eyes was demonstrated by fluorescence spectroscopy. Two other animals were treated with liposomally encapsulated 3H-8-MOP, and specific delivery of the drug to the treated lenses was demonstrated by phosphorescence spectroscopy and by liquid scintillation counting. The drugs delivered to the treated eyes could not be detected in any of the tissues or fluids of the contralateral control eyes. Except for the ocular lens, these agents could not be demonstrated to any substantial degree in the other tissues of the treated eyes.
Insights
This pilot study shows targeted liposomes delivered drugs specifically to rabbit ocular lenses using miniosmotic pumps. This targeted ocular drug delivery method shows promise for treating eye conditions.
Area of Science:
- Ophthalmology
- Pharmacology
- Biotechnology
Background:
- Ocular drug delivery presents challenges due to the eye's complex anatomy and physiological barriers.
- Targeted delivery systems are needed to enhance therapeutic efficacy and minimize systemic side effects.
Purpose of the Study:
- To evaluate the feasibility of using miniosmotic pumps with targeted liposomes for in vivo ocular lens drug delivery in rabbits.
- To assess the specificity and efficiency of this novel drug delivery system.
Main Methods:
- Miniosmotic pumps were implanted to deliver agents encapsulated in specifically targeted liposomes.
- Concanavalin A was used for targeted liposome delivery to the ocular lens.
- Fluorescence spectroscopy, phosphorescence spectroscopy, and liquid scintillation counting were used to quantify drug presence.
Main Results:
- Specific delivery of Sorbinil and 3H-8-MOP to the ocular lenses of treated eyes was demonstrated.
- No significant drug presence was detected in contralateral control eyes or other tissues of treated eyes.
Conclusions:
- The combination of miniosmotic pumps and targeted liposomes is a feasible method for direct ocular lens drug delivery in vivo.
- This approach offers high specificity, targeting the ocular lens while minimizing off-target distribution.